Paul F. Lizzul - Net Worth and Insider Trading

Paul F. Lizzul Net Worth

The estimated net worth of Paul F. Lizzul is at least $236,873 dollars as of 2024-05-12. Paul F. Lizzul is the Chief Medical Officer of AnaptysBio Inc and owns about 10,118 shares of AnaptysBio Inc (ANAB) stock worth over $236,862. Paul F. Lizzul is also the Chief Medical Officer of Sienna Biopharmaceuticals Inc and owns about 105,191 shares of Sienna Biopharmaceuticals Inc (SNNAQ) stock worth over $11. Details can be seen in Paul F. Lizzul's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Paul F. Lizzul has not made any transactions after 2024-01-08 and currently still holds the listed stock(s).

Transaction Summary of Paul F. Lizzul

To

Paul F. Lizzul Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Paul F. Lizzul owns 2 companies in total, including AnaptysBio Inc (ANAB) , and Sienna Biopharmaceuticals Inc (SNNAQ) .

Click here to see the complete history of Paul F. Lizzul’s form 4 insider trades.

Insider Ownership Summary of Paul F. Lizzul

Ticker Comapny Transaction Date Type of Owner
ANAB AnaptysBio Inc 2024-01-08 Chief Medical Officer
SNNAQ Sienna Biopharmaceuticals Inc 2019-08-06 Chief Medical Officer

Paul F. Lizzul Latest Holdings Summary

Paul F. Lizzul currently owns a total of 2 stocks. Among these stocks, Paul F. Lizzul owns 10,118 shares of AnaptysBio Inc (ANAB) as of January 8, 2024, with a value of $236,862 and a weighting of 100%. Paul F. Lizzul also owns 105,191 shares of Sienna Biopharmaceuticals Inc (SNNAQ) as of August 1, 2017, with a value of $11 and a weighting of 0%.

Latest Holdings of Paul F. Lizzul

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ANAB AnaptysBio Inc 2024-01-08 10,118 23.41 236,862
SNNAQ Sienna Biopharmaceuticals Inc 2017-08-01 105,191 0.00 11

Holding Weightings of Paul F. Lizzul


Paul F. Lizzul Form 4 Trading Tracker

According to the SEC Form 4 filings, Paul F. Lizzul has made a total of 2 transactions in AnaptysBio Inc (ANAB) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in AnaptysBio Inc is the sale of 2,554 shares on January 8, 2024, which brought Paul F. Lizzul around $55,703.

According to the SEC Form 4 filings, Paul F. Lizzul has made a total of 0 transactions in Sienna Biopharmaceuticals Inc (SNNAQ) over the past 5 years. The most-recent trade in Sienna Biopharmaceuticals Inc is the acquisition of 10,000 shares on August 1, 2017, which cost Paul F. Lizzul around $150,000.

Insider Trading History of Paul F. Lizzul

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Paul F. Lizzul Trading Performance

GuruFocus tracks the stock performance after each of Paul F. Lizzul's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul F. Lizzul is -3.77%. GuruFocus also compares Paul F. Lizzul's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul F. Lizzul within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Paul F. Lizzul's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Paul F. Lizzul

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 18.66
Relative Return to S&P 500(%) 18.65

Paul F. Lizzul Ownership Network

Ownership Network List of Paul F. Lizzul

No Data

Ownership Network Relation of Paul F. Lizzul


Paul F. Lizzul Owned Company Details

What does AnaptysBio Inc do?

Who are the key executives at AnaptysBio Inc?

Paul F. Lizzul is the Chief Medical Officer of AnaptysBio Inc. Other key executives at AnaptysBio Inc include General Counsel Eric J Loumeau , Chief Financial Officer Dennis Mulroy , and 10 percent owner Ecor1 Capital, Llc .

AnaptysBio Inc (ANAB) Insider Trades Summary

Over the past 18 months, Paul F. Lizzul made 2 insider transaction in AnaptysBio Inc (ANAB) with a net sale of 4,659. Other recent insider transactions involving AnaptysBio Inc (ANAB) include a net sale of 14,187 shares made by Eric J Loumeau , a net sale of 11,245 shares made by Dennis Mulroy , and a net sale of 155,806 shares made by Daniel Faga .

In summary, during the past 3 months, insiders sold 153,940 shares of AnaptysBio Inc (ANAB) in total and bought 0 shares, with a net sale of 153,940 shares. During the past 18 months, 185,897 shares of AnaptysBio Inc (ANAB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 185,897 shares.

AnaptysBio Inc (ANAB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

AnaptysBio Inc Insider Transactions

No Available Data

Paul F. Lizzul Mailing Address

Above is the net worth, insider trading, and ownership report for Paul F. Lizzul. You might contact Paul F. Lizzul via mailing address: 30699 Russell Ranch Road, Suite 140, Westlake Village Ca 91362.

Discussions on Paul F. Lizzul

No discussions yet.